{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:16:48Z","timestamp":1792793808039,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82388201"],"award-info":[{"award-number":["82388201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Aberrant expression and subcellular location of innate sensors in cancer cells, such as Toll-like receptors (TLRs), correlates with pro-tumoral inflammation and cancer progression, but the mechanism is still largely unknown. Deciphering the proinflammatory mediators in tumor microenvironment will contribute to the development of cancer therapeutics. By using immunohistochemistry in pancreatic ductal adenocarcinoma (PDAC) and multiple other cancer samples, here we found that cancer cell TLR3, a well-known cytoplasmic dsRNA sensor, translocated to the nucleus especially upon chemotherapy stress. Nuclear TLR3 increased the invasive and proliferative properties, and inhibited chemotherapy-induced apoptosis of cancer cells in vitro. Meanwhile, mice bearing cancer cells with nuclear TLR3 exhibited increased liver metastasis and shortened survival. Mechanistically, phosphokinase JAK1 was responsible for TLR3 phosphorylation at S155 to induce its nuclear translocation in cooperation with a nuclear transport factor importin \u03b15. Chemotherapeutic stress induced the aberrant aggregation of dsRNA in the nucleus, which potentially contributed to nuclear TLR3 activation. Then nuclear TLR3 recruited protein arginine methyltransferase 5 (PRMT5) and bound to c-Myc to promote symmetrical dimethylation and multimerization of c-Myc, resulting in the activation of c-Myc downstream target genes and pro-tumoral signaling pathways. Accordingly, high levels of cancer cell nuclear TLR3 in clinical samples predicted patients\u2019 worse prognosis with shorter disease-free survival, overall survival and poor response to neoadjuvant chemotherapy. Therefore, the identification of nuclear TLR3 provides new insight into non-classical functions of innate immune sensors in cancer, and JAK1\/TLR3\/PRMT5\/c-Myc axis may sever as a potential prognostic indicator and therapeutic target to overcome chemoresistance.<\/jats:p>","DOI":"10.1038\/s41392-025-02307-7","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T23:02:03Z","timestamp":1752793323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Phosphorylated Toll-like receptor 3 nuclear translocation in cancer cell promotes metastasis and chemoresistance"],"prefix":"10.1038","volume":"10","author":[{"given":"Zixin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2923-0729","authenticated-orcid":false,"given":"Yanfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6720-4732","authenticated-orcid":false,"given":"Ziqiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9677-7647","authenticated-orcid":false,"given":"Xuetao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"2307_CR1","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","volume":"180","author":"KA Fitzgerald","year":"2020","unstructured":"Fitzgerald, K. A. & Kagan, J. C. Toll-like receptors and the control of immunity. Cell 180, 1044\u20131066 (2020).","journal-title":"Cell"},{"key":"2307_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1146\/annurev-pathmechdis-012419-032847","volume":"15","author":"J Zindel","year":"2020","unstructured":"Zindel, J. & Kubes, P. DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation. Annu. Rev. Pathol. 15, 493\u2013518 (2020).","journal-title":"Annu. Rev. Pathol."},{"key":"2307_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri.2015.8","volume":"16","author":"X Cao","year":"2016","unstructured":"Cao, X. Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease. Nat. Rev. Immunol. 16, 35\u201350 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"2307_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-immunol-093019-123619","volume":"39","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. & Cao, X. Epigenetic remodeling in innate immunity and inflammation. Annu. Rev. Immunol. 39, 279\u2013311 (2021).","journal-title":"Annu. Rev. Immunol."},{"key":"2307_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-immunol-032414-112240","volume":"33","author":"SW Brubaker","year":"2015","unstructured":"Brubaker, S. W., Bonham, K. S., Zanoni, I. & Kagan, J. C. Innate immune pattern recognition: a cell biological perspective. Annu. Rev. Immunol. 33, 257\u2013290 (2015).","journal-title":"Annu. Rev. Immunol."},{"key":"2307_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","volume":"20","author":"T Gong","year":"2020","unstructured":"Gong, T., Liu, L., Jiang, W. & Zhou, R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat. Rev. Immunol. 20, 95\u2013112 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"2307_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","volume":"620","author":"MF Gulen","year":"2023","unstructured":"Gulen, M. F. et al. cGAS-STING drives ageing-related inflammation and neurodegeneration. Nature 620, 374\u2013380 (2023).","journal-title":"Nature"},{"key":"2307_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41568-022-00462-5","volume":"22","author":"SM Man","year":"2022","unstructured":"Man, S. M. & Jenkins, B. J. Context-dependent functions of pattern recognition receptors in cancer. Nat. Rev. Cancer 22, 397\u2013413 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"2307_CR9","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1053\/j.gastro.2006.06.017","volume":"131","author":"M Fukata","year":"2006","unstructured":"Fukata, M. et al. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 131, 862\u2013877 (2006).","journal-title":"Gastroenterology"},{"key":"2307_CR10","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nm1589","volume":"13","author":"H Kanzler","year":"2007","unstructured":"Kanzler, H., Barrat, F. J., Hessel, E. M. & Coffman, R. L. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat. Med. 13, 552\u2013559 (2007).","journal-title":"Nat. Med."},{"key":"2307_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41586-022-05254-3","volume":"610","author":"S Li","year":"2022","unstructured":"Li, S. et al. STING-induced regulatory B cells compromise NK function in cancer immunity. Nature 610, 373\u2013380 (2022).","journal-title":"Nature"},{"key":"2307_CR12","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1158\/2159-8290.CD-20-0465","volume":"11","author":"J Le Naour","year":"2021","unstructured":"Le Naour, J. et al. A TLR3 ligand reestablishes chemotherapeutic responses in the context of FPR1 deficiency. Cancer Discov. 11, 408\u2013423 (2021).","journal-title":"Cancer Discov."},{"key":"2307_CR13","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1158\/0008-5472.CAN-22-3023","volume":"83","author":"F Exposito","year":"2023","unstructured":"Exposito, F. et al. PTEN loss confers resistance to anti-PD-1 therapy in non-small cell lung cancer by increasing tumor infiltration of regulatory T cells. Cancer Res. 83, 2513\u20132526 (2023).","journal-title":"Cancer Res."},{"key":"2307_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41392-023-01479-4","volume":"8","author":"Y Gu","year":"2023","unstructured":"Gu, Y. et al. Incorporation of a Toll-like receptor 2\/6 agonist potentiates mRNA vaccines against cancer and infectious diseases. Signal Transduct. Target Ther. 8, 273 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"2307_CR15","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1016\/j.molimm.2007.01.022","volume":"44","author":"W He","year":"2007","unstructured":"He, W. et al. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol. Immunol. 44, 2850\u20132859 (2007).","journal-title":"Mol. Immunol."},{"key":"2307_CR16","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.intimp.2008.08.009","volume":"8","author":"Q Sun","year":"2008","unstructured":"Sun, Q., Zheng, Y., Liu, Q. & Cao, X. Rapamycin reverses TLR4 signaling-triggered tumor apoptosis resistance by disrupting Akt-mediated Bcl-xL upregulation. Int Immunopharmacol. 8, 1854\u20131858 (2008).","journal-title":"Int Immunopharmacol."},{"key":"2307_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41591-018-0309-y","volume":"25","author":"Y Gu","year":"2019","unstructured":"Gu, Y. et al. Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG. Nat. Med. 25, 312\u2013322 (2019).","journal-title":"Nat. Med."},{"key":"2307_CR18","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.1158\/0008-5472.CAN-05-0784","volume":"65","author":"B Huang","year":"2005","unstructured":"Huang, B. et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res. 65, 5009\u20135014 (2005).","journal-title":"Cancer Res."},{"key":"2307_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1118721","volume":"14","author":"WV Velasco","year":"2023","unstructured":"Velasco, W. V. et al. Toll-like receptors 2, 4, and 9 modulate promoting effect of COPD-like airway inflammation on K-ras-driven lung cancer through activation of the MyD88\/NF-\u0138B pathway in the airway epithelium. Front. Immunol. 14, 1118721 (2023).","journal-title":"Front. Immunol."},{"key":"2307_CR20","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1158\/0008-5472.CAN-09-1162","volume":"70","author":"AI Chin","year":"2010","unstructured":"Chin, A. I. et al. Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance. Cancer Res. 70, 2595\u20132603 (2010).","journal-title":"Cancer Res."},{"key":"2307_CR21","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1038\/onc.2013.302","volume":"33","author":"JP Pradere","year":"2014","unstructured":"Pradere, J. P., Dapito, D. H. & Schwabe, R. F. The Yin and Yang of Toll-like receptors in cancer. Oncogene 33, 3485\u20133495 (2014).","journal-title":"Oncogene"},{"key":"2307_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1136\/jitc-2024-008799","volume":"12","author":"D Jeon","year":"2024","unstructured":"Jeon, D., Hill, E., Moseman, J. E. & McNeel, D. G. Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy. J. Immunother. Cancer 12, 5 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"2307_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ccell.2016.06.021","volume":"30","author":"Y Liu","year":"2016","unstructured":"Liu, Y. et al. Tumor exosomal RNAs promote lung pre-metastatic niche formation by activating alveolar epithelial TLR3 to recruit neutrophils. Cancer Cell 30, 243\u2013256 (2016).","journal-title":"Cancer Cell"},{"key":"2307_CR24","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1126\/science.aav0758","volume":"365","author":"L Wang","year":"2019","unstructured":"Wang, L., Wen, M. & Cao, X. Nuclear hnRNPA2B1 initiates and amplifies the innate immune response to DNA viruses. Science 365, 6454 (2019).","journal-title":"Science"},{"key":"2307_CR25","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.molcel.2018.07.034","volume":"71","author":"G Dunphy","year":"2018","unstructured":"Dunphy, G. et al. Non-canonical activation of the DNA sensing adaptor STING by ATM and IFI16 mediates NF-\u03baB signaling after nuclear DNA damage. Mol. Cell 71, 745\u2013760 (2018).","journal-title":"Mol. Cell"},{"key":"2307_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-018-0629-6","volume":"563","author":"H Liu","year":"2018","unstructured":"Liu, H. et al. Nuclear cGAS suppresses DNA repair and promotes tumorigenesis. Nature 563, 131\u2013136 (2018).","journal-title":"Nature"},{"key":"2307_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/cdd.2014.145","volume":"22","author":"D Jia","year":"2015","unstructured":"Jia, D. et al. \u03b2-Catenin and NF-\u03baB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer. Cell Death Differ. 22, 298\u2013310 (2015).","journal-title":"Cell Death Differ."},{"key":"2307_CR28","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.2147\/JIR.S348786","volume":"15","author":"R Su","year":"2022","unstructured":"Su, R. et al. TLR3 expression is a potential prognosis biomarker and shapes the immune-active tumor microenvironment in esophageal squamous cell carcinoma. J. Inflamm. Res. 15, 1437\u20131456 (2022).","journal-title":"J. Inflamm. Res."},{"key":"2307_CR29","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/ncb2629","volume":"14","author":"W Yang","year":"2012","unstructured":"Yang, W. et al. ERK1\/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat. Cell Biol. 14, 1295\u20131304 (2012).","journal-title":"Nat. Cell Biol."},{"key":"2307_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41422-022-00628-8","volume":"32","author":"X Lu","year":"2022","unstructured":"Lu, X. et al. EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription. Cell Res. 32, 359\u2013374 (2022).","journal-title":"Cell Res."},{"key":"2307_CR31","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.immuni.2024.05.025","volume":"57","author":"H Xu","year":"2024","unstructured":"Xu, H. et al. Cellular spermine targets JAK signaling to restrain cytokine-mediated autoimmunity. Immunity 57, 1796\u20131811 (2024).","journal-title":"Immunity"},{"key":"2307_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cell.2023.11.027","volume":"187","author":"M Tamari","year":"2024","unstructured":"Tamari, M. et al. Sensory neurons promote immune homeostasis in the lung. Cell 187, 44\u201361 (2024).","journal-title":"Cell"},{"key":"2307_CR33","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","volume":"375","author":"JM Zaretsky","year":"2016","unstructured":"Zaretsky, J. M. et al. Mutations associated with acquired resistance to PD-1 blockade in melanoma. N. Engl. J. Med. 375, 819\u2013829 (2016).","journal-title":"N. Engl. J. Med."},{"key":"2307_CR34","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature23477","volume":"548","author":"SJ Patel","year":"2017","unstructured":"Patel, S. J. et al. Identification of essential genes for cancer immunotherapy. Nature 548, 537\u2013542 (2017).","journal-title":"Nature"},{"key":"2307_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49667-2","volume":"15","author":"L Yu","year":"2024","unstructured":"Yu, L. et al. Co-targeting JAK1\/STAT6\/GAS6\/TAM signaling improves chemotherapy efficacy in Ewing sarcoma. Nat. Commun. 15, 5292 (2024).","journal-title":"Nat. Commun."},{"key":"2307_CR36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cmet.2024.10.015","volume":"37","author":"R Zhu","year":"2025","unstructured":"Zhu, R. et al. ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion. Cell Metab. 37, 361\u2013376 (2025).","journal-title":"Cell Metab."},{"key":"2307_CR37","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.addr.2007.11.005","volume":"60","author":"M Matsumoto","year":"2008","unstructured":"Matsumoto, M. & Seya, T. TLR3: interferon induction by double-stranded RNA including poly(I:C). Adv. Drug Deliv. Rev. 60, 805\u2013812 (2008).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"2307_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.13022","volume":"304","author":"D Thoresen","year":"2021","unstructured":"Thoresen, D. et al. The molecular mechanism of RIG-I activation and signaling. Immunol. Rev. 304, 154\u2013168 (2021).","journal-title":"Immunol. Rev."},{"key":"2307_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/sj.cr.7310019","volume":"16","author":"RB Seth","year":"2006","unstructured":"Seth, R. B., Sun, L. & Chen, Z. J. Antiviral innate immunity pathways. Cell Res. 16, 141\u2013147 (2006).","journal-title":"Cell Res."},{"key":"2307_CR40","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.cels.2018.03.003","volume":"6","author":"FX Schaub","year":"2018","unstructured":"Schaub, F. X. et al. Pan-cancer alterations of the MYC oncogene and its proximal network across the Cancer Genome Atlas. Cell Syst. 6, 282\u2013300 (2018).","journal-title":"Cell Syst."},{"key":"2307_CR41","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1158\/2159-8290.CD-19-0435","volume":"10","author":"NM Sodir","year":"2020","unstructured":"Sodir, N. M. et al. MYC instructs and maintains pancreatic adenocarcinoma phenotype. Cancer Discov. 10, 588\u2013607 (2020).","journal-title":"Cancer Discov."},{"key":"2307_CR42","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1158\/2159-8290.CD-19-0620","volume":"10","author":"N Muthalagu","year":"2020","unstructured":"Muthalagu, N. et al. Repression of the type I interferon pathway underlies MYC- and KRAS-dependent evasion of NK and B cells in pancreatic ductal adenocarcinoma. Cancer Discov. 10, 872\u2013887 (2020).","journal-title":"Cancer Discov."},{"key":"2307_CR43","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrc3984","volume":"15","author":"TR Kress","year":"2015","unstructured":"Kress, T. R., Sab\u00f2, A. & Amati, B. MYC: connecting selective transcriptional control to global RNA production. Nat. Rev. Cancer 15, 593\u2013607 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"2307_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a014357","volume":"4","author":"M Conacci-Sorrell","year":"2014","unstructured":"Conacci-Sorrell, M., McFerrin, L. & Eisenman, R. N. An overview of MYC and its interactome. Cold Spring Harb. Perspect. Med. 4, 1 (2014).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2307_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","volume":"19","author":"R Dhanasekaran","year":"2022","unstructured":"Dhanasekaran, R. et al. The MYC oncogene\u2014the grand orchestrator of cancer growth and immune evasion. Nat. Rev. Clin. Oncol. 19, 23\u201336 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2307_CR46","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-022-05469-4","volume":"612","author":"D Solvie","year":"2022","unstructured":"Solvie, D. et al. MYC multimers shield stalled replication forks from RNA polymerase. Nature 612, 148\u2013155 (2022).","journal-title":"Nature"},{"key":"2307_CR47","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41573-021-00159-8","volume":"20","author":"Q Wu","year":"2021","unstructured":"Wu, Q., Schapira, M., Arrowsmith, C. H. & Barsyte-Lovejoy, D. Protein arginine methylation: from enigmatic functions to therapeutic targeting. Nat. Rev. Drug Discov. 20, 509\u2013530 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2307_CR48","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00018-015-1847-9","volume":"72","author":"N Stopa","year":"2015","unstructured":"Stopa, N., Krebs, J. E. & Shechter, D. The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond. Cell Mol. Life Sci. 72, 2041\u20132059 (2015).","journal-title":"Cell Mol. Life Sci."},{"key":"2307_CR49","doi-asserted-by":"publisher","first-page":"112252","DOI":"10.1016\/j.biopha.2021.112252","volume":"144","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Targeting protein arginine methyltransferase 5 in cancers: Roles, inhibitors and mechanisms. Biomed. Pharmacother. 144, 112252 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"2307_CR50","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.gendis.2019.06.002","volume":"6","author":"F Zhu","year":"2019","unstructured":"Zhu, F. & Rui, L. PRMT5 in gene regulation and hematologic malignancies. Genes Dis. 6, 247\u2013257 (2019).","journal-title":"Genes Dis."},{"key":"2307_CR51","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1080\/21691401.2019.1671857","volume":"47","author":"W Du","year":"2019","unstructured":"Du, W. et al. Circ-PRMT5 promotes gastric cancer progression by sponging miR-145 and miR-1304 to upregulate MYC. Artif. Cells Nanomed. Biotechnol. 47, 4120\u20134130 (2019).","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"2307_CR52","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-020-2774-y","volume":"586","author":"B Tavora","year":"2020","unstructured":"Tavora, B. et al. Tumoural activation of TLR3-SLIT2 axis in endothelium drives metastasis. Nature 586, 299\u2013304 (2020).","journal-title":"Nature"},{"key":"2307_CR53","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1093\/jnci\/djs436","volume":"104","author":"V Chew","year":"2012","unstructured":"Chew, V. et al. Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients. J. Natl Cancer Inst. 104, 1796\u20131807 (2012).","journal-title":"J. Natl Cancer Inst."},{"key":"2307_CR54","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1126\/science.ade8520","volume":"384","author":"J Zak","year":"2024","unstructured":"Zak, J. et al. JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma. Science 384, 6702 (2024).","journal-title":"Science"},{"key":"2307_CR55","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1126\/science.adf1329","volume":"384","author":"D Mathew","year":"2024","unstructured":"Mathew, D. et al. Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients. Science 384, 6702 (2024).","journal-title":"Science"},{"key":"2307_CR56","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/s41556-024-01473-0","volume":"9","author":"G Lv","year":"2024","unstructured":"Lv, G. et al. mTORC2-driven chromatin cGAS mediates chemoresistance through epigenetic reprogramming in colorectal cancer. Nat. Cell Biol. 9, 1585\u20131596 (2024).","journal-title":"Nat. Cell Biol."},{"key":"2307_CR57","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41392-018-0019-4","volume":"3","author":"W Han","year":"2018","unstructured":"Han, W. et al. A nanomedicine approach enables co-delivery of cyclosporin A and gefitinib to potentiate the therapeutic efficacy in drug-resistant lung cancer. Signal Transduct. Target Ther. 3, 16 (2018).","journal-title":"Signal Transduct. Target Ther."},{"key":"2307_CR58","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/17401","volume":"397","author":"M Hojo","year":"1999","unstructured":"Hojo, M. et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 397, 530\u2013534 (1999).","journal-title":"Nature"},{"key":"2307_CR59","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.tcb.2004.07.016","volume":"14","author":"DS Goldfarb","year":"2004","unstructured":"Goldfarb, D. S., Corbett, A. H., Mason, D. A., Harreman, M. T. & Adam, S. A. Importin alpha: a multipurpose nuclear-transport receptor. Trends Cell Biol. 14, 505\u2013514 (2004).","journal-title":"Trends Cell Biol."},{"key":"2307_CR60","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/1098-2264(200007)28:3<329::AID-GCC11>3.0.CO;2-F","volume":"28","author":"C Stock","year":"2000","unstructured":"Stock, C., Kager, L., Fink, F. M., Gadner, H. & Ambros, P. F. Chromosomal regions involved in the pathogenesis of osteosarcomas. Genes Chromosomes Cancer 28, 329\u2013336 (2000).","journal-title":"Genes Chromosomes Cancer"},{"key":"2307_CR61","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/318533a0","volume":"318","author":"JM Adams","year":"1985","unstructured":"Adams, J. M. et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318, 533\u2013538 (1985).","journal-title":"Nature"},{"key":"2307_CR62","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/modpathol.2008.111","volume":"21","author":"B Gurel","year":"2008","unstructured":"Gurel, B. et al. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. Mod. Pathol. 21, 1156\u20131167 (2008).","journal-title":"Mod. Pathol."},{"key":"2307_CR63","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-023-06256-5","volume":"619","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Reprogramming tumour-associated macrophages to outcompete cancer cells. Nature 619, 616\u2013623 (2023).","journal-title":"Nature"},{"key":"2307_CR64","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1126\/science.aac9935","volume":"352","author":"SC Casey","year":"2016","unstructured":"Casey, S. C. et al. MYC regulates the antitumor immune response through CD47 and PD-L1. Science 352, 227\u2013231 (2016).","journal-title":"Science"},{"key":"2307_CR65","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1038\/s42255-023-00915-7","volume":"11","author":"P Kreuzaler","year":"2023","unstructured":"Kreuzaler, P. et al. Vitamin B5 supports MYC oncogenic metabolism and tumor progression in breast cancer. Nat. Metab. 11, 1870\u20131886 (2023).","journal-title":"Nat. Metab."},{"key":"2307_CR66","doi-asserted-by":"publisher","first-page":"8728","DOI":"10.18632\/aging.103198","volume":"12","author":"L Tan","year":"2020","unstructured":"Tan, L. et al. High PRMT5 expression is associated with poor overall survival and tumor progression in bladder cancer. Aging (Albany NY) 12, 8728\u20138741 (2020).","journal-title":"Aging (Albany NY)"},{"key":"2307_CR67","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.canlet.2018.04.019","volume":"427","author":"P Jing","year":"2018","unstructured":"Jing, P. et al. Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family\/FGFR3 signaling. Cancer Lett. 427, 38\u201348 (2018).","journal-title":"Cancer Lett."},{"key":"2307_CR68","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/ijc.31909","volume":"144","author":"H Lattouf","year":"2019","unstructured":"Lattouf, H. et al. LKB1 regulates PRMT5 activity in breast cancer. Int J. Cancer 144, 595\u2013606 (2019).","journal-title":"Int J. Cancer"},{"key":"2307_CR69","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3892\/ijo.2017.3833","volume":"50","author":"D Shimizu","year":"2017","unstructured":"Shimizu, D. et al. The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy. Int J. Oncol. 50, 381\u2013386 (2017).","journal-title":"Int J. Oncol."},{"key":"2307_CR70","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.oraloncology.2018.09.015","volume":"86","author":"H-C Chuang","year":"2018","unstructured":"Chuang, H.-C., Chou, M.-H., Chien, C.-Y., Chuang, J.-H. & Liu, Y.-L. Triggering TLR3 pathway promotes tumor growth and cisplatin resistance in head and neck cancer cells. Oral. Oncol. 86, 141\u2013149 (2018).","journal-title":"Oral. Oncol."},{"key":"2307_CR71","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/nm.3708","volume":"20","author":"A Sistigu","year":"2014","unstructured":"Sistigu, A. et al. Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nat. Med. 20, 1301\u20131309 (2014).","journal-title":"Nat. Med."},{"key":"2307_CR72","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41586-024-07835-w","volume":"632","author":"A Prashar","year":"2024","unstructured":"Prashar, A. et al. Lysosomes drive the piecemeal removal of mitochondrial inner membrane. Nature 632, 1110\u20131117 (2024).","journal-title":"Nature"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02307-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02307-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02307-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:31:21Z","timestamp":1757219481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02307-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2307"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02307-7","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"25 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. Xuetao Cao is one of the Associate Editors of Signal Transduction and Targeted Therapy, but he has not been involved in the process of the manuscript handling.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"225"}}